FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persistersMengjiao Li, Noriko Gotoh, Kang Wang et al.|Journal of Clinical Investigation|2023Cited by 29
Displacement of Native FXYD Protein From Na+/K+-ATPase With Novel FXYD Peptide Derivatives: Effects on Doxorubicin CytotoxicityChia‐Chi Liu, H Rasmussen|Frontiers in Oncology|2022Cited by 8
Na+/K+-ATPase-associated FXYD3 Protein As An Intracellular Therapeutic Target in CancerChia‐Chi Liu, H Rasmussen|Unknown|2020Cited by 0